Sialyl-nLc4Cer (d20:1/8:0) is a glycosphingolipid subtype, which can be used as an effective standard for research on the development of cancer inhibitors.
CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.